Table 5.
(95% CI) | RR | |
---|---|---|
Factors associated with severe hypoglycemia (SeH) | ||
Diameter ≥ 4 cm | 2.33–5.28 | 3.36 |
Abdominal site | 1.45–2.68 | 2.24 |
LHs on multiple sites | 1.97–2.89 | 2.35 |
Injection into LH nodules | 2.48–4.25 | 3.86 |
Needle reuse | 2.12–3.79 | 3.18 |
Failure to rotate injection site | 2.89–4.66 | 3.52 |
Insulin dose > 40 IU/day | 1.16–2.08 | 1.75 |
Needle length ≥ 6 mm | 0.88–2.98 | 2.06 |
Ice-cold insulin | 1.25–2.86 | 1.85 |
Factors associated with symptomatic hypoglycemia (SyH) | ||
Abdominal site | 1.22–2.63 | 2.17 |
LHs on more than one site | 1.88–2.93 | 2.41 |
Injection into LH nodules | 2.55–5.87 | 4.03 |
Needle reuse | 2.55–6.32 | 4.41 |
Failure to rotate injection site | 2.46–3.54 | 2.69 |
Insulin dose > 40 IU/day | 1.93–2.81 | 2.01 |
Post-injection drop leaking | 0.98–1.98 | 1.32 |
Ice-cold insulin | 1.06–2.16 | 1.38 |
Results of Poisson multivariate analysis showing only significant RRs (95% CI). For acronyms, please refer to the text